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Background: A inherited or acquired disorders and conditions may present in 
conjunction with moyamoya disease. This condition is known as quasi-moyamoya 
disease. Methods: A retrospective review of 69 moyamoya disease patients treated for 
the past 20 years identified seven patients of quasi-moyamoya disease and five of them 
were pediatric patients. Results: The mean age at initial diagnosis was 6.4 year-old 
(range 5 to 9). Associated disorders were as follows; craniosynostosis, dwarfism with 
coarctation of aorta, Proteus syndrome, cranial irradiation for brain tumor. Their clinical 
type included cerebral ischemia in three patients, cerebral bleeding with ischemia in one 
and epilepsy in one. Three patients with cerebral ischemia underwent bypass surgery 
and their ischemia was improved. One patient died of brain tumor recurrence and the 
activity of daily living was affected by mental retardation due to associated disorder. 
Conclusions: The clinical course and radiological finding of quasi-moyamoya disease 
are diverse because of associated disorders, distinguishing definite moyamoya disease.  
 





Moyamoya disease is characterized by the progressive occlusion of the internal carotid 
artery (ICA) or its terminal branches, accompanied by the formation of extensive 
collateral vessels (moyamoya vessels) at the base of the brain. This disease has been 
reported in association with various disease entities including atherosclerosis, 
autoimmune disease, meningitis, brain tumor, neurofibromatosis type 1, Down 
syndrome, cranial irradiation and so on [1-3]. These conditions are distinguished from 
moyamoya disease according to the diagnostic criteria of the Research Committee on 
Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis) of Ministry of 
Health and Welfare of Japan (RCMJ), and named as quasi-moyamoya disease [4, 5]. 
Since the incidence of quasi-moyamoya disease is quite rare, the clinical course has 
been unclear and the consensus for the treatment has not been established. We 
retrospectively reviewed our experience of quasi-moyamoya disease, and the clinical 




Materials and Methods 
 
Moyamoya disease patients diagnosed at Nagasaki University Hospital from 1985 to 
2005 were retrospectively reviewed. Fifty-two patients were diagnosed as definite 
moyamoya disease based on the guidelines for the diagnosis of moyamoya disease set 
by RCMJ. Unilateral moyamoya disease (probable moyamoya disease) and 
quasi-moyamoya disease was defined angiographically and identified in 9 and 7 patients 
respectively. The associated disorders of quasi-moyamoya disease were 
craniosynostosis, neurofibromatosis type 1, dwarfism with coarctation of aorta, Proteus 
syndrome, cranial irradiation for brain tumor and atherosclerosis. Among 7 patients of 
quasi-moyamoya disease, 5 patients were less than 15-years-old. We analyzed medical 
history, age at onset, first sign at onset angiographic stage (Suzuki classification), 
ischemic or hemorrhagic lesions on CT or MRI, findings of hemodynamic 
hypoperfusion or decreased vascular reactivity to acetazolamide on single photon 
emission tomography (SPECT). Thus, surgical treatment was attempted when severe 
cerebral hypoperfusion was revealed. Patients were followed clinically and 
radiologically. When the progressing of the occlusive lesion in the major intracranial 






Baseline patient characteristics of quasi-moyamoya disease were summarized 
in table 1. The male-to-female ratio was 4 to 1, and the mean age at initial diagnosis was 
6.4 year-old (range 5 to 9). Their clinical symptoms were complicated because 
preexisted neurological symptoms and acquired disorders were mixed. Clinical 
classification included ischemic type in three patients, bleeding with ischemia type in 
one, epilepsy in one. Mental retardation had been found in four patients and visual 
disturbance was identified in one case of brain tumor. Angiographically, all patient had 
bilateral lesion. The initial angiographic stages by Suzuki were grade III (n=4) or IV 
(n=1). Thus, stenosis was found in the terminal portion of the ICA or the horizontal 
portion of the middle cerebral artery (MCA). Moyamoya vessels were seen bilaterally in 
all patients. The collateral flow from external carotid artery was well developed in two 
cranial irradiation patients.  
Three patients underwent vascular reconstruction namely 
encephalo-duro-arterio-synostosis (EDAS) or superficial temporal artery (STA)-MCA 
anastomosis combination with encephalo-myo-synangiosis (EMS). Postoperative 
courses were uneventful and the ischemic attack has disappeared. Vascular 
reconstruction was not employed for two cases of brain tumor, since collateral flow 
from external carotid artery had been developed. The patients have been followed by 
noting clinical symptoms and by SPECT, MRI including MR angiography. Mean 
follow-up duration was 11.0 years, ranging 3 to 20 years. Angiographical disease 
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progression was observed in two cases of cranial irradiation for brain tumor. One patient 
died of brain tumor recurrence and the other 4 patients of daily life was influenced with 





A 6-year-old boy who had craniosynostosis (Fig. 1A) and mental retardation, and had 
been diagnosed as Saethre-Chotzen syndrome presented because of gait disturbance. 
MRI showed multiple lacuna infarctions (Fig. 1B). Cerebral hypoperfusion was 
revealed by SPECT especially in the left cerebral hemisphere (Fig. 1C). Angiography 
revealed severe stenosis steno-occlusive lesion at the terminal portion of the ICA and 
horizontal portion of the middle cerebral artery (Fig. 1D-F). Moyamoya vessels were 
significantly developed bilaterally. He underwent EDAS bilaterally and disease 
progression has not been observed. However, he needs some supports on his daily life 
because of mental retardation.  
 
Patient 3 
A 6-year-old boy visited our hospital because of right hemiparesis. He had been 
followed by pediatrician for left arm hypertrophy and mental retardation. Thus, his 
distinctive face indicated Proteus syndrome (Fig. 2A). CT demonstrated right thalamic 
hemorrhage with left frontal and right parietal infarction (Fig. 2B). The lesions 
 
 7
confirmed with MRI and left frontal lesion was revealed as fresh lesion (Fig. 2C, D). 
Cerebral perfusion was impaired bilaterally (Fig. 2E). Angiography showed 
steno-occlusive lesion at the terminal portion of the bilateral ICA (Fig. 2F, G). 
Moyamoya vessels were massively developed especially in the right side. Posterior 
cerebral arteries were also involved (Fig. 2H). Collateral flow from external carotid 
artery (ECA) was slightly seen (Fig. 2I, J). STA-MCA anastomosis combination with 
EMS was performed bilaterally. Postoperative course was uneventful. However, he need 
some supports on his daily life because of mental retardation.  
 
Patient 4 
A-5-year-old boy, who has a history of partial removal of left temporal glioma with 
local irradiation, presented because of incidentally found cerebral infarction. MRI 
showed right frontal infarction as well as residual tumor in the left temporal lobe (Fig. 
3A). SPECT revealed hypoperfusion in the right frontal and left parietal lobe (Fig. 3B). 
Steno-occlusive lesion was found at the terminal portion of the bilateral ICA and 
moyamoya vessels were developed (Fig. 3C-E). Collateral flow from ECA was 
significantly developed (Fig. 3F, G).  Reoperation was performed for the recurrence of 
the tumor. He was followed clinically and radiologically. Additional ischemic lesion has 







According to the diagnostic criteria of the RCMJ, the etiology of moyamoya disease is 
unknown and the condition associated with atherosclerosis, autoimmune disease, 
meningitis and so on, are distinguished from definite moyamoya disease [4, 5]. Since 
the terminology for this condition has not been defined, several words have been used to 
mean this condition as quasi-moyamoya disease, akin-moyamoya disease, moyamoya 
syndrome, moyamoya phenomenon, moyamoya-like vasculopathy and so on [1, 3, 6, 7]. 
We employed the term “quasi-moyamoya disease” throughout this report because it was 
given by Dr. Suzuki, who reported “moyamoya disease” at first [5]. This incidence of 
quasi-moyamoya disease (7/69=10.8%) was consistent with previous Japanese reports, 
which demonstrated approximately 10% of moyamoya disease [8]. The ratio of 
quasi-moyamoya disease is higher in western country [7]. Among seven patients of 
moyamoya syndrome, five were pediatric patients. Table 1 provides a summary of the 
clinical data obtained from the five quasi-moyamoya disease patients. The mean age 
was 6.4-year-old. It is well known that patients with moyamoya disease are 
predominantly female and we have demonstrated that the moyamoya syndrome affected 
patients are predominantly male. In terms of patient ages, it has been reported that there 
are two peaks, namely child type and adult type [9, 10]. In this series, child types are 




Symptoms and Sings 
The clinical manifestation of quasi-moyamoya disease are complicated since the aspect 
of cerebrovascular disorder and that of associated disorder are merged. Interestingly, 
mental retardation was seen in the most congenital disorder. Regarding with 
cerebrovascular disorder, four patients suffered ischemia and one patient had both 
hemorrhage and ischemia. As shown in Fig. 2B, the hemorrhage was seen in the right 
thalamus, which was unusual as moyamoya disease. 
 
Radiological findings 
We identified a wide variety of angiographical lesions in our series. All patients had 
arterial steno-occlusion with formation of moyamoya vessels bilaterally. Moyamoya 
disease associated with Down syndrome or neurofibromatosis type 1 occasionally 
involves only unilateral side [1, 11]. Moyamoya vessels were well developed in 
congenital disorders and were not significant in irradiated brain tumor patients. 
Collateral flow form ECA was significantly dominant in irradiated brain tumor patients. 
[12]. Posterior circulation was involved in three patients. Taken together, angiographical 
finding of quasi-moyamoya disease is widely varied.  
 
Treatment and prognosis  
In terms of treatment of quasi-moyamoya disease, vascular recanalization was 
performed for the patient with symptom or cerebral hypoperfusion revealed by SPECT.  
Two patients underwent STA-MCA direct bypass procedure. Indirect vascular 
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reconstruction was performed to two patients. Postoperative course was uneventful. 
Thus, vascular reconstruction was effective to prevent disease progression and cerebral 
hypoperfusion was improved postoperatively. Moyamoya disease, particularly in 
children, often exhibit progression during follow-up. Among our quasi-moyamoya 
disease patients, angiographical progression was seen in two irradiated brain tumor 
patients. In these two patients, vascular reconstruction was not employed for them, since 
collateral flow from ECA had been developed. Finally, activity of daily living of the 
patients was influenced with symptoms such as mental retardation due to associated 
disorder. And one patient died of brain tumor recurrence.  
 
Genetic analysis 
The pathologic and epidemiological facts suggest that genetic factors play a more 
important role in the pathogenesis of moyamoya disease than do acquired factors [13]. 
The familial occurrence was approximately 10% of moyamoya disease patients [14, 15]. 
Previous linkage studies have indicated that susceptibility loci for the moyamoya 
disease are located on chromosome 3p24.2-26, 6q, 8q23 and 17q25 [13, 16-18]. 
Mineharu et al reported that the mode of inheritance of familial moyamoya disease is 
autosomal dominant with incomplete penetrance [19]. Several genetic factors in 
different loci cause the same disease (locus heterogeneity). Thus, the coincidence of 
unilateral and definite moyamoya disease within a single family indicates that they 
reflect different phenotypes cause by the same genetic defects [20]. Some of the 
congenital disorders namely neurofibromatosis type 1, of which responsible gene is 
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located on chromosome 17q11.2 may be related to the same gene with moyamoya 
disease. Others such as Down syndrome are cased by completely different gene, but 
manifest similar cerebral vascular disease.  
 
Limitation 
The incidence of moyamoya disease is estimated to be 0.54 per 100.000 populations and 
that of quasi- moyamoya disease is as low as 10% of moyamoya disease [21].   
Therefore, it is difficult to demonstrate clinical feature of quasi- moyamoya disease. 
Nation wide study is required to clarify the clinical feature of quasi- moyamoya disease 





Among five cases of quasi-moyamoya disease, no one exhibited typical clinical course 
of moyamoya disease. Clinical manifestation and pathophysiology of quasi-moyamoya 
disease were diverse according to their associated disorders. Vascular reconstruction 
prevented disease progression and the prognosis of the quasi-moyamoya disease was 
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Fig. 1 Patient 1 
A 6-year-old boy with Saethre-Chotzen syndrome.   
Three-dimensional skull bone CT showed craniosynostosis (A). MRI (T2 weighted 
image) showed multiple lacuna infarctions (B). Cerebral hypoperfusion was revealed by 
single photon emission tomography (SPECT) especially in the left frontal lobe (C). 
Angiography reveal steno-occlusive lesion at the terminal portion of the bilateral 
internal carotid artery (ICA; D, E). Moyamoya vessels were also developed bilaterally. 
Posterior circulation was not involved (F).   
 
Fig. 2 Patient 3 
A 6-year-old boy with Proteus syndrome.  
Distinctive face with left arm hypertrophy were seen (A). CT demonstrated right 
thalamic hemorrhage with left frontal and right parietal infarction (B), and lesions were 
confirmed by MRI (inversion recovery image; C). MRI (diffusion-weighted image) 
showed left frontal lesion as fresh lesion (D). Cerebral perfusion was impaired 
bilaterally (E). Angiography showed steno-occlusive lesion at the terminal portion of 
the bilateral ICA (F, G). Moyamoya vessels were developed especially in the right side. 
Pial anastomosis from the left posterior cerebral artery was developed (H). Collateral 




Fig. 3 Patient 4 
A-5-year-old boy with left temporal glioma and cranial irradiation. 
MRI (inversion recovery image) showed residual tumor in the left temporal lobe as well 
as right frontal infarction (A). SPECT revealed hypoperfusion in the right frontal and 
left parietal lobe (B). Steno-occlusive lesion was found at the terminal portion of the 
bilateral ICA and moyamoya vessels were developed (C, D). Pial anastomosis from the 
right posterior cerebral artery was developed (E). Collateral flow from ECA was 



















 Table 1 patient characteristics of quasi-moyamoya disease 
Age, sex disease  symptom  imaging study   treatment  follow (years) 
  
1) 6 M craniosynostois gate disturbance   cerebral infarction   Bil. EDAS  14   
    (mental returdation)  
 
2) 9 M dwarfism  epilepsy    no abnormality  Bil. EDAS  20 
 coarctation of aorta  
 
3) 6 M Proteus syndrome TIA    cerebral infarction  Bil. STA-MCA  3 
   (mental returdation) intracerebral hemorrhge  with EMS 
 
4) 5 M BT/irradiation (mental returdation)  cerebral infarction   (removal)  13  
      (brin tumor) 
 
5) 6 F BT/irradiation  (visual disturbance)  cerebral infarction  (removal)  5  (dead) 
(mental returdation)  (brain tumor) 
 
M: male, F: female, NF: neurofibromatosis type 1, BT: brain tumor, TIA: transient ischemic attack, Bil: bilateral 
EDAS: encephalo-duro-arterio-synostosis, STA-MCA: superficial temporal artery-middle cerebral artery anastomosis 
( ) indicates findings due to associated disorder or treatment for the disorder.  
